A 4‐site, single‐visit intradermal postexposure prophylaxis regimen for previously vaccinated patients: experiences with >5000 patients

Clin Infect Dis. 2010 Nov 1;51(9):1070-2. doi: 10.1086/656585.

Abstract

We previously demonstrated that 4‐site, intradermal, single‐visit rabies booster vaccination provides immunogenicity greater than that provided by the standard 2‐booster, 2‐visit regimen. The regimen has been routinely used in 5116 patients since 1998 without any treatment failure. It is not only effective but also saves vaccine costs and transportation expenses and improves compliance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Bites and Stings / complications
  • Child
  • Child, Preschool
  • Humans
  • Immunization, Secondary / methods*
  • Injections, Intradermal
  • Male
  • Middle Aged
  • Rabies / prevention & control*
  • Rabies Vaccines / administration & dosage*
  • Rabies Vaccines / immunology*
  • Retrospective Studies
  • Thailand
  • Treatment Outcome
  • Young Adult

Substances

  • Rabies Vaccines